Global Implantable Hearing Devices Market

Global Implantable Hearing Devices Market Size, Trends & Analysis - Forecast to 2026 By Product (Active Hearing Implants, Passive Hearing Implants), By Type (Cochlear Implants, Middle Ear Implants, Bone Conduction Implants, Auditory Brainstem Implant), By Patient Type (Adult, Paediatric), By End-Use (Hospitals, ENT, Ambulatory Surgical Centres), By Region (North America, Asia Pacific, Europe, Latin America, Middle East & Africa); End-User Landscape, Company Market Share Analysis, and Competitor Analysis

Category Healthcare

Format

This report was recently updated on November 17 2024 with the latest and most recent market numbers

Implantable Hearing Devices Market Insights

Genetic mutation, complications during birth, chronic ear infection, and excessive noise and ageing pollution are major factors causing otic disorder among a large number of the population. As per WHO, it is estimated that more than 900 million people are expected to be diagnosed with hearing loss by 2050. Thus, the introduction of devices which can implant in the ears will support the healthcare industry.

Favourable government regulations in terms of commercialization and availability of wide products will stimulate the Implantable Hearing Devices Market growth. Facilities such as product availability on OTC and other retail outlets will instigate product penetration. The ear implants are technologically advanced prosthetic components widely used in treating deafness and otic disorder.

The otic disorder can be categorized into two types i.e. sensorineural and conductive. Sensorineural loss is permanent and can be caused due to ageing and excessively loud noise exposure for a prolonged period. Among infants and children, the disorder can happen due to congenital abnormalities and infection. In this disorder, the high pitched tones are sounded muffled which makes it difficult to pick words with high background noises.

The conductive otic disorder happens when a person finds difficulty in listening due tothe inability to transfer sound waves. In most cases, these are temporary disordersthat can be treated through medical assistance. Fluid in the ear, earwax, infection, and object stuck in the outer ear are major reasons to diagnose conductive otic disorder. Increasing consumer awareness pertaining to the treatment of hearing loss along with the availability of various treatments and devices will drive the implantable hearing devices market.

global implantable hearing devices market

Implantable Hearing Devices Market: By Product

Active and passive are two implantable hearing devices available in the market. Active products include any device featuring electrical or digital parts which aid in suppressing and amplifying noise from the patient’s background and surrounding. While passive aids are more mechanical inclined products that receive greater directional acoustic waves. They also overpower unnecessary acoustic waves for better results. Active implantable devices will witness the highest gains during the forecast period. More compatibility and better results are major reasons to drive demand in this segment.

Implantable Hearing Devices Market: By Type

Cochlear implants, middle ear implants, bone conduction implants, and auditory brainstem implant are major types included in the implantable hearing devices industry. Cochlear implants are expected to dominate the industry in the coming years. An increasing number of patients diagnosed with cochlear disorder along with a high success rate are key factors influencing the growth.

Bone conduction implants will witness the highest growth during the forecast period. Technological advancements along with a high replacement rate of bone conduction aids to implants will benefit the industry growth.

Implantable Hearing Devices Market: By Patient Type

Adult and Paediatric are two patient categories in the industry. Children born with listening difficulties due to genetic mutations, complication during delivery, and other disorder are gaining high attention in this industry. The Healthcare industry is keen on developing products and solutions to overcome communication difficulties among the younger generation. With the presence of various permanent treatments, the parents are keen to opt for the surgeries.

Among adults the disorder can be occurred due to a noisy environment, hereditary, infection, and other bone disorders. Availability of wide treatments with effective results along with increased consumer spending on medical services will stimulate market growth.

Implantable Hearing Devices Market: By End-Use

Hospitals, ENT, and ambulatory surgical centres are major end-users in the industry. Hospitals are expected to gain maximum share during the forecast period. High patient engagement along with the presence of multiple departments with specialists are major factors to drive demand in this segment. Other factors such as government support, subsidy, and compensation to certain patient categories will instigate the demand.

ENT is projected to witness the highest CAGR in the coming years. The increasing number of individual practitioners along with the availability of facilities in the clinics will drive the growth in this segment. Procedure and technological advancement along with increasing surgical practitioners will induce the penetration in ENT segment.

asia pacific implantable hearing devices market

Implantable Hearing Devices Market: By Region

Europe will hold themajorshare in the coming years. Significant growth in the healthcare sector along with government regulations to offer better treatment will influence regional growth. Germany industrial growth will be highly inclined towards product innovation and aligning with regulatory guidelines by adopting sustainable health solution.

Asia Pacific Implantable Hearing Devices Market will gain the highest CAGR during the forecast period. Healthcare industry expansionaccompanied by high demand for implants surgery rather than ear aid productsare major factors contributingto regional industry growth. China, South Korea, and India are key contributing countries.

Implantable Hearing Devices Market Share and Competitor Analysis

The company market share is highly competitive due to the presence of key players holding a maximum share. Cochlear, William Demant, MED-EL, Advanced Bionics, Ototronix, Nurotron Biotechnology, Envoy Medical Corporation, Sonova Holding, Medtronic, GN Re Sound, Starkey Hearing Technologies, Sivantos Group/ Widex, Gn Store Nord, Widex, Sebotek Hearing Systems, Zounds Hearing, Audina Hearing Instruments, Microson, Rion, Horentek, and Arphi Electronics are major contributors in the industry company market share.

Please note: This is not an exhaustive list of companies profiled in the report.

Chapter 1 Methodology

1.1 Market scope & definitions

1.2 Estimates & forecast calculation

1.3 Historical data overview and validation

1.4 Data sources

1.4.1 Secondary

1.4.2 Primary

Chapter 2 Report Outlook

2.1 Implantable Hearing Devices industry overview, 2016-2026

2.1.1 Industry overview

2.1.2 Product overview

2.1.3 Type overview

2.1.4 Patient type overview

2.1.5 End-Use overview

2.1.6 Regional overview

Chapter 3 Implantable Hearing Devices Market Trends

3.1 Market segmentation

3.2 Industry background, 2016-2026

3.3 Market key trends

3.3.1 Positive trends

3.3.2 Industry challenges

3.4 Prospective growth scenario

3.5 COVID-19 influence over industry growth

3.6 Porter’s analysis

3.7 PESTEL analysis

3.8 Value chain & supply chain analysis

3.9 Regulatory framework

3.9.1 North America

3.9.2 Europe

3.9.3 APAC

3.9.4 LATAM

3.9.5 MEA

3.10 Technology overview

3.10.1 Devices

3.10.2 End-Use

3.11 Market share analysis, 2020

3.11.1 Company positioning overview, 2020

Chapter 4 Implantable Hearing Devices Market, By Product

4.1 Product Outlook

4.2 Active Hearing Implants

4.2.1 Market size, by region, 2016-2026 (USD Million)

4.3 Passive Hearing Implants

4.3.1 Market size, by region, 2016-2026 (USD Million)

Chapter 5 Implantable Hearing Devices Market, By Type

5.1 Type Outlook

5.2 Cochlear Implants

5.2.1 Market size, by region, 2016-2026 (USD Million)

5.3 Middle Ear Implants

5.3.1 Market size, by region, 2016-2026 (USD Million)

5.4 Bone conduction Implants

5.4.1 Market size, by region, 2016-2026 (USD Million)

5.5 Auditory brainstem implant

5.5.1 Market size, by region, 2016-2026 (USD Million)

5.6 Others

5.6.1 Market size, by region, 2016-2026 (USD Million)

Chapter 6 Implantable Hearing Devices Market, By Patient Type

6.1 Patient Type Outlook

6.2 Adult

6.2.1 Market size, by region, 2016-2026 (USD Million)

6.3 Paediatric

6.3.1 Market size, by region, 2016-2026 (USD Million)

Chapter 7 Implantable Hearing Devices Market, By End-Use

7.1 End-Use Outlook

7.2 Hospitals

7.2.1 Market size, by region, 2016-2026 (USD Million)

7.3 ENT

7.3.1 Market size, by region, 2016-2026 (USD Million)

7.4 Ambulatory Surgical Centres

7.4.1 Market size, by region, 2016-2026 (USD Million)

Chapter 8 Implantable Hearing Devices Market, By Region

8.1 Regional outlook

8.2 North America

8.2.1 Market size, by country 2016-2026 (USD Million)

8.2.2 Market size, by product, 2016-2026 (USD Million)

8.2.3 Market size, by type, 2016-2026 (USD Million)

8.2.4 Market size, by patient type, 2016-2026 (USD Million)

8.2.5 Market size, by end-use, 2016-2026 (USD Million)

8.2.6 U.S.

8.2.6.1 Market size, by product, 2016-2026 (USD Million)

8.2.6.2 Market size, by type, 2016-2026 (USD Million)

8.2.6.3 Market size, by patient type, 2016-2026 (USD Million)

8.2.6.4 Market size, by end-use, 2016-2026 (USD Million)

8.2.7 Canada

8.2.7.1 Market size, by product, 2016-2026 (USD Million)

8.2.7.2 Market size, by type, 2016-2026 (USD Million)

8.2.7.3 Market size, by patient type, 2016-2026 (USD Million)

8.2.7.4 Market size, by end-use, 2016-2026 (USD Million)

8.3 Europe

8.3.1 Market size, by country 2016-2026 (USD Million)

8.3.2 Market size, by product, 2016-2026 (USD Million)

8.3.3 Market size, by type, 2016-2026 (USD Million)

8.3.4 Market size, by patient type, 2016-2026 (USD Million)

8.3.5 Market size, by end-use, 2016-2026 (USD Million)

8.3.6 Germany

8.2.6.1 Market size, by product, 2016-2026 (USD Million)

8.2.6.2 Market size, by type, 2016-2026 (USD Million)

8.2.6.3 Market size, by patient type, 2016-2026 (USD Million)

8.2.6.4 Market size, by end-use, 2016-2026 (USD Million)

8.3.7 UK

8.3.7.1 Market size, by product, 2016-2026 (USD Million)

8.3.7.2 Market size, by type, 2016-2026 (USD Million)

8.3.7.3 Market size, by patient type, 2016-2026 (USD Million)

8.3.7.4 Market size, by end-use, 2016-2026 (USD Million)

8.3.8 France

8.3.8.1 Market size, by product, 2016-2026 (USD Million)

8.3.8.2 Market size, by type, 2016-2026 (USD Million)

8.3.8.3 Market size, by patient type, 2016-2026 (USD Million)

8.3.8.4 Market size, by end-use, 2016-2026 (USD Million)

8.3.9 Italy

8.3.9.1 Market size, by product, 2016-2026 (USD Million)

8.3.9.2 Market size, by type, 2016-2026 (USD Million)

8.3.9.3 Market size, by patient type, 2016-2026 (USD Million)

8.3.9.4 Market size, by end-use, 2016-2026 (USD Million)

8.3.10 Spain

8.3.10.1 Market size, by product, 2016-2026 (USD Million)

8.3.10.2 Market size, by type, 2016-2026 (USD Million)

8.3.10.3 Market size, by patient type, 2016-2026 (USD Million)

8.3.10.4 Market size, by end-use, 2016-2026 (USD Million)

8.3.11 Russia

8.3.11.1 Market size, by product, 2016-2026 (USD Million)

8.3.11.2 Market size, by type, 2016-2026 (USD Million)

8.3.11.3 Market size, by patient type, 2016-2026 (USD Million)

8.3.11.4 Market size, by end-use, 2016-2026 (USD Million)

8.4 Asia Pacific

8.4.1 Market size, by country 2016-2026 (USD Million)

8.4.2 Market size, by product, 2016-2026 (USD Million)

8.4.3 Market size, by type, 2016-2026 (USD Million)

8.4.4 Market size, by patient type, 2016-2026 (USD Million)

8.4.5 Market size, by end-use, 2016-2026 (USD Million)

8.4.6 China

8.4.6.1 Market size, by product, 2016-2026 (USD Million)

8.4.6.2 Market size, by type, 2016-2026 (USD Million)

8.4.6.3 Market size, by patient type, 2016-2026 (USD Million)

8.4.6.4 Market size, by end-use, 2016-2026 (USD Million)

8.4.7 India

8.4.7.1 Market size, by product, 2016-2026 (USD Million)

8.4.7.2 Market size, by type, 2016-2026 (USD Million)

8.4.7.3 Market size, by patient type, 2016-2026 (USD Million)

8.4.7.4 Market size, by end-use, 2016-2026 (USD Million)

8.4.8 Japan

8.4.8.1 Market size, by product, 2016-2026 (USD Million)

8.4.8.2 Market size, by type, 2016-2026 (USD Million)

8.4.8.3 Market size, by patient type, 2016-2026 (USD Million)

8.4.8.4 Market size, by end-use, 2016-2026 (USD Million)

8.4.9 Australia

8.4.9.1 Market size, by product, 2016-2026 (USD Million)

8.4.9.2 Market size, by type, 2016-2026 (USD Million)

8.4.9.3 Market size, by patient type, 2016-2026 (USD Million)

8.4.9.4 Market size, by end-use, 2016-2026 (USD Million)

8.4.10 South Korea

8.4.10.1 Market size, by product, 2016-2026 (USD Million)

8.4.10.2 Market size, by type, 2016-2026 (USD Million)

8.4.10.3 Market size, by patient type, 2016-2026 (USD Million)

8.4.10.4 Market size, by end-use, 2016-2026 (USD Million)

8.5 Latin America

8.5.1 Market size, by country 2016-2026 (USD Million)

8.5.2 Market size, by product, 2016-2026 (USD Million)

8.5.3 Market size, by type, 2016-2026 (USD Million)

8.5.4 Market size, by patient type, 2016-2026 (USD Million)

8.5.5 Market size, by end-use, 2016-2026 (USD Million)

8.5.6 Brazil

8.5.6.1 Market size, by product, 2016-2026 (USD Million)

8.5.6.2 Market size, by type, 2016-2026 (USD Million)

8.5.6.3 Market size, by patient type, 2016-2026 (USD Million)

8.5.6.4 Market size, by end-use, 2016-2026 (USD Million)

8.5.7 Mexico

8.5.7.1 Market size, by product, 2016-2026 (USD Million)

8.5.7.2 Market size, by type, 2016-2026 (USD Million)

8.5.7.3 Market size, by patient type, 2016-2026 (USD Million)

8.5.7.4 Market size, by end-use, 2016-2026 (USD Million)

8.5.8 Argentina

8.5.8.1 Market size, by product, 2016-2026 (USD Million)

8.5.8.2 Market size, by type, 2016-2026 (USD Million)

8.5.8.3 Market size, by patient type, 2016-2026 (USD Million)

8.5.8.4 Market size, by end-use, 2016-2026 (USD Million)

8.6 MEA

8.6.1 Market size, by country 2016-2026 (USD Million)

8.6.2 Market size, by product, 2016-2026 (USD Million)

8.6.3 Market size, by type, 2016-2026 (USD Million)

8.6.4 Market size, by patient type, 2016-2026 (USD Million)

8.6.5 Market size, by end-use, 2016-2026 (USD Million)

8.6.6 Saudi Arabia

8.6.6.1 Market size, by product, 2016-2026 (USD Million)

8.6.6.2 Market size, by type, 2016-2026 (USD Million)

8.6.6.3 Market size, by patient type, 2016-2026 (USD Million)

8.6.6.4 Market size, by end-use, 2016-2026 (USD Million)

8.6.7 UAE

8.6.7.1 Market size, by product, 2016-2026 (USD Million)

8.6.7.2 Market size, by type, 2016-2026 (USD Million)

8.6.7.3 Market size, by patient type, 2016-2026 (USD Million)

8.6.7.4 Market size, by end-use, 2016-2026 (USD Million)

8.6.8 South Africa

8.6.8.1 Market size, by product, 2016-2026 (USD Million)

8.6.8.2 Market size, by type, 2016-2026 (USD Million)

8.6.8.3 Market size, by patient type, 2016-2026 (USD Million)

8.6.8.4 Market size, by end-use, 2016-2026 (USD Million)

Chapter 9 Company Landscape

9.1 Competitive analysis, 2020

9.2 Cochlear Ltd.

9.2.1 Company overview

9.2.2 Financial analysis

9.2.3 Strategic positioning

9.2.4 Info graphic analysis

9.3 MED-EL

9.3.1 Company overview

9.3.2 Financial analysis

9.3.3 Strategic positioning

9.3.4 Info graphic analysis

9.4 William Demant Holding A/S

9.4.1 Company overview

9.4.2 Financial analysis

9.4.3 Strategic positioning

9.4.4 Info graphic analysis

9.5 Advanced Bionics AG

9.5.1 Company overview

9.5.2 Financial analysis

9.5.3 Strategic positioning

9.5.4 Info graphic analysis

9.6 Nurotron Biotechnology Co. Ltd.

9.6.1 Company overview

9.6.2 Financial analysis

9.6.3 Strategic positioning

9.6.4 Info graphic analysis

9.7 Ototronix

9.7.1 Company overview

9.7.2 Financial analysis

9.7.3 Strategic positioning

9.7.4 Info graphic analysis

9.8 Envoy Medical Corporation

9.8.1 Company overview

9.8.2 Financial analysis

9.8.3 Strategic positioning

9.8.4 Info graphic analysis

9.9 Medtronic

9.9.1 Company overview

9.9.2 Financial analysis

9.9.3 Strategic positioning

9.9.4 Info graphic analysis

9.10 Sonova Holding AG

9.10.1 Company overview

9.10.2 Financial analysis

9.10.3 Strategic positioning

9.10.4 Info graphic analysis

9.11 GN Re Sound

9.11.1 Company overview

9.11.2 Financial analysis

9.11.3 Strategic positioning

9.11.4 Info graphic analysis

9.12 Sivantos Group/ Widex

9.12.1 Company overview

9.12.2 Financial analysis

9.12.3 Strategic positioning

9.12.4 Info graphic analysis

9.13 Starkey Hearing Technologies, Inc.

9.13.1 Company overview

9.13.2 Financial analysis

9.13.3 Strategic positioning

9.13.4 Info graphic analysis

9.14 Gn Store Nord

9.14.1 Company overview

9.14.2 Financial analysis

9.14.3 Strategic positioning

9.14.4 Info graphic analysis

9.15 Widex

9.15.1 Company overview

9.15.2 Financial analysis

9.15.3 Strategic positioning

9.15.4 Info graphic analysis

9.16 Zounds Hearing

9.16.1 Company overview

9.16.2 Financial analysis

9.16.3 Strategic positioning

9.16.4 Info graphic analysis

9.17 Sebotek Hearing Systems

9.17.1 Company overview

9.17.2 Financial analysis

9.17.3 Strategic positioning

9.17.4 Info graphic analysis

9.18 Audina Hearing Instruments

9.18.1 Company overview

9.18.2 Financial analysis

9.18.3 Strategic positioning

9.18.4 Info graphic analysis

9.19 Rion

9.19.1 Company overview

9.19.2 Financial analysis

9.19.3 Strategic positioning

9.19.4 Info graphic analysis

9.20 Horentek

9.20.1 Company overview

9.20.2 Financial analysis

9.20.3 Strategic positioning

9.20.4 Info graphic analysis

9.21 Microson

9.21.1 Company overview

9.21.2 Financial analysis

9.21.3 Strategic positioning

9.21.4 Info graphic analysis

9.22 Arphi Electronics

9.22.1 Company overview

9.22.2 Financial analysis

9.22.3 Strategic positioning

9.22.4 Info graphic analysis

The Global Implantable Hearing Devices Market has been studied from the year 2019 till 2026. However, the CAGR provided in the report is from the year 2021 to 2026. The research methodology involved three stages: Desk research, Primary research, and Analysis & Output from the entire research process.

The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply-side analysis for the Implantable Hearing Devices Market.

The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.

Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the company and customer analytics.